Tympanometers Market Size, Share and Global Trend By Product (Handheld Tympanometers, Tympanometers With Built-In Printers, Others), By End User (Hospitals, Clinics, Others) and Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
Tympanometry provides valuable quantitative information regarding the presence of fluid in the middle ear, the mobility of the middle ear and volume of the ear canal. Tympanometer is a device which is used to obtain quantitative clinical information about the functioning and presence of fluid in the middle ear. Tympanometer is helpful in the diagnosis of otitis media effusion, acute otitis media, tenderness or soreness of the ear, otitis externa, excessive wax, and others.
The Commonwealth of Australia mentioned in their Aboriginal and Torres Strait Islander Health Performance Report 2017, from 2012 to 2013, almost 12% of all indigenous Australians had ear problem. There are also increased instances of noise pollution leading to hearing problems. According to WHO, 1.1 billion young people between the age group 12-35 years are at the risk of hearing problems due to increased exposure to noise.
To gain extensive insights into the market, Request for Customization
The tympanometers market growth is driven by the increase in the prevalence of hearing disorders and rapid technological advancements in the tympanometers. In 2017, PATH Medical Solutions introduced Sentiero Diagnostic Desktop, that included air or bone or speech audiometry along with features such as multi-frequency probe tone, Eustachian Tube Function (ETF), manual pump control, ipsilateral or contralateral acoustic reflexes with reflex decay. Similarly, Interacoustics A/S, launched AT235, an automatic middle ear analyzer with child distraction function which will aid in case of pediatric patients.
The high cost of tympanometers is the major restraining factor in the growth of tympanometers market.
Key Players Covered
Some of the major companies that are present in the tympanometers market are PATH Medical Solutions, Grason- Standler Inc., MAICO Diagnostic GmbH, Welch Allyn Inc., Interacoustics A/S, Intelligent Hearing Systems, MedRx, Intermedics Supply Inc., Natus (Otometrics), Mimosa Acoustics Inc., Otodynamics Ltd., INVENTIS SRL., and other players.
SEGMENTATION
SEGMENTATION | DETAILS |
By Product | · Handheld Tympanometers · Tympanometers With Built-In Printers · Others |
By End-User | · Hospitals · Clinics · Others |
By Geography | · North America (the USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa) |
Among end-users, the hospital's segment is anticipated to dominate the tympanometers market size in the forecast period due to growing awareness among parents for a newborn hearing screening.
Key Insights
- Prevalence of Hearing Disorders, 2018, Key Countries
- Pricing Analysis, 2018, Key Countries/ Regions
- Recent industry developments such as partnerships, mergers, and acquisitions
Regional Analysis
North America accounted for the highest share in global tympanometry market. Strong healthcare infrastructure and rise in instances of ear problem due to noise pollution are some of the factors expected to drive the tympanometers market growth in the region. The global tympanometers market is projected to flourish in both Europe and the Asia Pacific by 2025, due to the increase in cases of hearing disorders.
Key Industry Developments
- In October 2018, Demant A/S launched GSI Allegro a new handheld screening tympanometers.
- In Feburary 2015, Amplivox Limited launched Otowave 202-H tympanometer featureing a range of test functions including user defined 1000Hz and 226Hz probe tone impedance measurements and a user programmable range of both contra lateral reflex test measurements at 500Hz, 1kHz, 2kHz and 4kHz and IPSI.
- Ongoing
- 2023
- 2019-2022
-
Get in Touch with Us
-
US +1 833 909 2966 ( Toll Free )
-
